Mankind Pharma Limited — Others, 07-08-2025: Shareholders meeting

Mankind Pharma held its 34th Annual General Meeting virtually, with 126 members attending. Shareholders adopted the audited financial statements for the fiscal year ended March 31, 2025. Key resolutions put to vote included the re-appointment of Director Mr. Sheetal Arora, the appointment of Secretarial Auditors, and the ratification of the Cost Auditor's remuneration for FY26. Management addressed shareholder queries. All resolutions are deemed passed pending the final e-voting results, marking key governance approvals and financial oversight for the company's operations.